Ovid Therapeutics Inc. logo

OVIDOvid Therapeutics Inc.

OVID Stock Price, Valuation & Chart | Ovid Therapeutics Inc.

Compare

OVID Historical price chart

OVID Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization505.79M
PE Ratio-9.34
EPS-0.29
Trading Volume1.56M
Today's High/Low2.87/2.68
Dividend Yield0.00
52 Week High/Low3.1/1.12
Shares Outstanding186.64M
OVID Financial Statement
OVID Analyst ratings
OVID Analysis & performance metrics

OVID Company profile

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is…

OVID Management team

Management
Zhong Zhong Ph.D.
Chief Scientific Officer
Tom Parry
Vice President of Research and Early Development
Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.CEO
Chief Executive Officer & Chairman
Julia Tsai Ph.D.
Senior Vice President of Clinical Development
Manal Morsy M.B.A., M.D., PH.D.
Chief Regulatory Officer
Margaret AlexanderCOO
President & Chief Operating Officer
Jeffrey A. Rona
Chief Business and Financial Officer
Dirk Haasner
Senior Vice President of Global Manufacturing & CMC QA
Total 8 executives

OVID Frequently asked questions

What is Ovid Therapeutics Inc. (OVID) Stock Price?

Current stock price of Ovid Therapeutics Inc. (OVID) stock is $2.710. The stock price is -1.81% lower in the session. The intraday range can be seen from this page. Volume of Ovid Therapeutics Inc. (OVID) stock is 1.56M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Ovid Therapeutics Inc. (OVID) stock price going up or down today?

The stock price of Ovid Therapeutics Inc. (OVID) can change with earnings, company news, and overall market sentiment. Ovid Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ovid Therapeutics Inc. stock expensive at its current price?

Whether Ovid Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for OVID on this page is -9.34. EPS on this page is -0.29. Compare those figures with peers and growth expectations before deciding if the current Ovid Therapeutics Inc. price is justified.

How has the stock price of Ovid Therapeutics Inc. (OVID) performed historically?

Historical performance for Ovid Therapeutics Inc. (OVID) is shown on the price chart on this page. Review multi-period moves alongside volume to see how OVID reacted to past earnings and market events.

Should I buy Ovid Therapeutics Inc. (OVID) stock, at this price?

Buying Ovid Therapeutics Inc. (OVID) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.